2023
DOI: 10.1038/s41593-023-01315-6
|View full text |Cite
|
Sign up to set email alerts
|

Tau activation of microglial cGAS–IFN reduces MEF2C-mediated cognitive resilience

Abstract: Pathological hallmarks of Alzheimer’s disease (AD) precede clinical symptoms by years, indicating a period of cognitive resilience before the onset of dementia. Here, we report that activation of cyclic GMP–AMP synthase (cGAS) diminishes cognitive resilience by decreasing the neuronal transcriptional network of myocyte enhancer factor 2c (MEF2C) through type I interferon (IFN-I) signaling. Pathogenic tau activates cGAS and IFN-I responses in microglia, in part mediated by cytosolic leakage of mitochondrial DNA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
47
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 63 publications
(49 citation statements)
references
References 69 publications
2
47
0
Order By: Relevance
“…Moreover, the treatment of microglia, the major site of pathogen detection in the brain, with Aβ fibrils, can promote the production of IFN‐I 14,16 . Tau fibrils may also promote microglial IFN‐I production, partially by promoting the release of mitochondrial deoxyribonucleic acid (DNA) into the cytosol 17 . However, the effects of IFN‐I on the development of tau pathology are unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the treatment of microglia, the major site of pathogen detection in the brain, with Aβ fibrils, can promote the production of IFN‐I 14,16 . Tau fibrils may also promote microglial IFN‐I production, partially by promoting the release of mitochondrial deoxyribonucleic acid (DNA) into the cytosol 17 . However, the effects of IFN‐I on the development of tau pathology are unclear.…”
Section: Introductionmentioning
confidence: 99%
“…8 A recent important study found that tau proteins are also involved in activating antiviral pathways and inhibit neuronal repair, ultimately leading to tau protein-induced cognitive impairment. 9 Furthermore, as research continues, evidence accumulates that supports the role of neuroinflammation, oxidative stress damage, and neuronal apoptosis in the pathogenesis of AD. 10 Although domestic and international research on AD continues unabated, many questions remain unresolved, and consequently, few new drugs have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of AD since 2003.…”
Section: Introductionmentioning
confidence: 99%
“…Hyperphosphorylated tau proteins cannot bind to microtubule proteins, forming NFTs . A recent important study found that tau proteins are also involved in activating antiviral pathways and inhibit neuronal repair, ultimately leading to tau protein-induced cognitive impairment . Furthermore, as research continues, evidence accumulates that supports the role of neuroinflammation, oxidative stress damage, and neuronal apoptosis in the pathogenesis of AD …”
Section: Introductionmentioning
confidence: 99%
“…Cellular secretions typically function as mediators of biosignal transduction and thus play an important role in a range of physiological and pathological processes. 1 For example, the levels of IFN-γ, IL-1b, IL-6, MCP-1, TNF-α, IL-2, and IL-5 are significantly elevated in the plasma of nasopharyngeal carcinoma (NPC) patients, subsequently undergoing a marked reduction following treatment. 2 Notably, as immune cells exhibit functional diversity, even the genetically homogeneous cells can demonstrate a range of different physiological functions, 3 due to the cell heterogeneous response to the varied clinical conditions.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Cellular secretions typically function as mediators of biosignal transduction and thus play an important role in a range of physiological and pathological processes . For example, the levels of IFN-γ, IL-1b, IL-6, MCP-1, TNF-α, IL-2, and IL-5 are significantly elevated in the plasma of nasopharyngeal carcinoma (NPC) patients, subsequently undergoing a marked reduction following treatment .…”
Section: Introductionmentioning
confidence: 99%